Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as an adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL) and to reduce the risk of cardiovascular events in certain patients with elevated triglycerides. FDA approved on July 26, 2012. It is grouped under the following drug class(es): Lipid-lowering agents. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Epadel, ethyl eicosapentaenoate, Vascepa and Timnodonic acid ethyl ester. Its PubChem CID is 9831415.
Icosapent ethyl
| CAS No | 73310-10-8 |
|---|---|
| Molecular Formula | C22H34O2 |
| Molecular Weight | 330.5 g/mol |
| Synonyms | ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as an adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL) and to reduce the risk of cardiovascular events in certain patients with elevated triglycerides.
The listed CAS number is 73310-10-8.
The listed molecular formula is C22H34O2.
The listed molecular weight is 330.5 g/mol.
ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate.
The source lists Epadel, ethyl eicosapentaenoate, Vascepa and Timnodonic acid ethyl ester.